Abstract
CART peptides are endogenous neurotransmitters that are involved in a variety of physiologic functions. Injection of CART 55-102 into the nucleus accumbens produces no effect, but when co-administered with cocaine, it reduces the locomotor and rewarding properties of cocaine. In a human study, subjects carrying a missense mutation of the CART gene exhibited increased anxiety and depression. Also, several animal studies support the idea that CART is involved in anxiety and depression, and they also suggest several possible mechanisms by which this may occur. Thus, there is interesting evidence that CART peptides play a role in anxiety and depression, and that CART peptides may be endogenous antidepressants.
Keywords: CART peptide, antidepressant, depression, forced swim test, anxiety, arousal, drug abuse, CART Peptides, Antidepressants, Psychostimulants, Endogenous, adrenocorticotropin hormone, hypothalamic-pituitary-somatotrophic (HPS) axis
Current Neuropharmacology
Title: CART Peptides Regulate Psychostimulants and May be Endogenous Antidepressants
Volume: 9 Issue: 1
Author(s): M. O. Job, I. M. McNamara and M. J. Kuhar
Affiliation:
Keywords: CART peptide, antidepressant, depression, forced swim test, anxiety, arousal, drug abuse, CART Peptides, Antidepressants, Psychostimulants, Endogenous, adrenocorticotropin hormone, hypothalamic-pituitary-somatotrophic (HPS) axis
Abstract: CART peptides are endogenous neurotransmitters that are involved in a variety of physiologic functions. Injection of CART 55-102 into the nucleus accumbens produces no effect, but when co-administered with cocaine, it reduces the locomotor and rewarding properties of cocaine. In a human study, subjects carrying a missense mutation of the CART gene exhibited increased anxiety and depression. Also, several animal studies support the idea that CART is involved in anxiety and depression, and they also suggest several possible mechanisms by which this may occur. Thus, there is interesting evidence that CART peptides play a role in anxiety and depression, and that CART peptides may be endogenous antidepressants.
Export Options
About this article
Cite this article as:
O. Job M., M. McNamara I. and J. Kuhar M., CART Peptides Regulate Psychostimulants and May be Endogenous Antidepressants, Current Neuropharmacology 2011; 9 (1) . https://dx.doi.org/10.2174/157015911795017074
DOI https://dx.doi.org/10.2174/157015911795017074 |
Print ISSN 1570-159X |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6190 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Rheumatic Manifestations in Malignancy
Current Rheumatology Reviews Alzheimers Disease: From Pathogenesis to Disease-Modifying Approaches
CNS & Neurological Disorders - Drug Targets The Stress Rheostat: An Interplay Between the Unfolded Protein Response (UPR) and Autophagy in Neurodegeneration
Current Molecular Medicine The Phosphodiesterase III Inhibitor Cilostazol Ameliorates Ethanolinduced Endothelial Dysfunction
Current Neurovascular Research Discovering Tumor Suppressor Genes Through Genome-Wide Copy Number Analysis
Current Genomics Halving Your Cake and Eating it, Too: A Case-based Discussion and Review of Metabolic Rehabilitation for Obese Adults with Diabetes
Current Diabetes Reviews Psychopharmacology of Attention-Deficit Hyperactivity Disorder: Effects and Side Effects
Current Pharmaceutical Design We are not Alone in Our Body: Insights into the Involvement of Microbiota in the Etiopathogenesis and Pharmacology of Mental Illness
Current Drug Metabolism Strategies for Design of Non Peptide CCK1R Agonist/Antagonist Ligands
Current Topics in Medicinal Chemistry CGRP, a Vasodilator Neuropeptide that Stimulates Neuromuscular Transmission and EC Coupling
Current Vascular Pharmacology Retraction Notice: Regulatory Chaperone Complexes in Neurodegenerative Diseases: A Perspective on Therapeutic Intervention
Current Alzheimer Research Comprehensive Assessment of Compliance with Antimuscarinic Drug Treatment in the Case of Urge Urinary Incontinence of Older Patients
Current Aging Science Inflammatory Process in Parkinsons Disease: Role for Cytokines
Current Pharmaceutical Design Dynamic Ventricular Repolarisation: From Physiology to Prognosis
Current Cardiology Reviews The Interleukin-1 System: An Attractive and Viable Therapeutic Target in Neurodegenerative Disease
Current Drug Targets - CNS & Neurological Disorders Synthetic Curcumin Analogs as Inhibitors of β -Amyloid Peptide Aggregation: Potential Therapeutic and Diagnostic Agents for Alzheimer's Disease
Mini-Reviews in Medicinal Chemistry Dermatologic Effects of Psychopharmacologic Agents in the Pediatric Population
Current Psychopharmacology Update of QSAR & Docking Studies of the GSK-3 Inhibitors
Current Bioinformatics Editorial (Thematic Issue: Neuroprotective Effects of Li - It is Elementary)
Current Alzheimer Research Nanostructured Lipid Carriers (NLCs) for Drug Delivery: Role of Liquid Lipid (Oil)
Current Drug Delivery